Xglar One

XGLAR ONE by ERIS LIFE SCIENCES LIMITED: Detailed Product Description

XGLAR ONE is a long-acting insulin analog developed by Eris Life Sciences Limited, designed to provide consistent blood sugar control for individuals with diabetes.

• Name

  • Brand Name: XGLAR ONE, XGLAR ONE PEN, XGLAR ONE 100IU Prefilled Syringe/Injection.
  • Common Name: Insulin Glargine.

• Composition

  • Active Ingredients: Insulin Glargine 100 IU/ml.

• Uses XGLAR ONE is indicated for the management of both type 1 and type 2 diabetes mellitus in adults and children. It functions by replacing the insulin naturally produced by the body, facilitating glucose uptake by cells, and suppressing glucose production by the liver. This helps maintain stable blood glucose levels throughout the day and night, reducing the risk of diabetes-related complications.

• Dosage and Administration XGLAR ONE is administered as a subcutaneous injection, typically once daily, at the same time each day. Injection sites should be rotated within the chosen area (e.g., abdomen, thighs, arms, hips, or buttocks) to prevent skin changes. For adults with type 2 diabetes, the initial dosage is usually 10 units or 0.2 units/kg, adjusted based on the patient's response. For individuals with type 1 diabetes or those requiring higher insulin doses, the initial dosage may vary and is determined by a healthcare professional. It is crucial to ensure the solution is colorless and free of particles before use.

• Side Effects

  • Common Side Effects: The most frequently reported side effect is hypoglycemia (low blood sugar), which can cause dizziness, sweating, anxiety, confusion, headache, blurred vision, shakiness, and fast heartbeat. Other common side effects include injection site reactions (pain, swelling, redness), peripheral edema (swelling in extremities), lipodystrophy (changes in fat tissue at the injection site), allergic reactions (rash, itching), and weight gain.
  • Serious Side Effects: Rare but serious side effects can include severe allergic reactions (hives, trouble breathing, fast heart rate, low blood pressure) and severe hypoglycemia leading to seizures or unconsciousness. Immediate medical attention is required for these symptoms.

• Precautions Patients should regularly monitor blood glucose levels to minimize the risk of hypoglycemia and carry a readily available source of sugar to counteract symptoms. Alcohol consumption should be limited as it can interfere with insulin's action and affect blood sugar levels. Caution is advised for patients with liver or kidney disease, as dose adjustment may be necessary. Pregnant or breastfeeding mothers should consult their doctor, as insulin doses may need to be adjusted. Driving or operating machinery should be avoided if experiencing symptoms of hypoglycemia. Certain medications like thiazolidinediones (TZDs) may increase the risk of heart failure, and gatifloxacin can affect blood glucose levels.

• Storage XGLAR ONE should be stored in a cool and dry place away from direct sunlight. It requires refrigeration, typically at 2ºC to 8ºC (cold chain), and should be kept out of the sight and reach of children.

XGLAR ONE, manufactured by Eris Life Sciences Limited, is a long-acting insulin analog used to manage blood sugar levels in individuals with diabetes. It contains Insulin Glargine.

Here are some frequently asked questions about XGLAR ONE:

What is XGLAR ONE used for?

XGLAR ONE is used to manage type 1 and type 2 diabetes mellitus in both adults and children. It helps control high blood glucose (sugar) levels and prevents diabetes-related complications such as kidney damage, vision impairment, and nerve damage.

How does XGLAR ONE work?

XGLAR ONE (Insulin Glargine) is a man-made, long-acting insulin that provides a consistent and prolonged effect on blood sugar levels throughout the day, lasting up to 24 hours. It works by mimicking the steady, basal insulin release of a healthy pancreas, facilitating the uptake of glucose from the bloodstream into muscle and fat cells, and suppressing the liver's production of glucose.

What is the usual dosage for XGLAR ONE?

The dosage of XGLAR ONE is individualized and determined by a healthcare professional based on the patient's specific needs, weight, and blood sugar levels. For adults with type 2 diabetes, the initial dosage is typically 10 units or 0.2 units/kg, which is then adjusted according to the patient's response. It is injected once daily, preferably at the same time each day, just below the skin (subcutaneously).

What are the possible side effects of XGLAR ONE?

The most common side effect is hypoglycemia (low blood sugar), which can cause dizziness, sweating, anxiety, confusion, headache, blurred vision, shakiness, and a fast heartbeat. Other potential side effects include peripheral edema (swelling), lipodystrophy (changes in fat tissue at the injection site), allergic reactions (rash, hives, itching, trouble breathing), and injection site reactions (pain, swelling, redness). Serious allergic reactions are rare but require immediate medical attention.

Is XGLAR ONE safe during pregnancy or breastfeeding?

During Pregnancy: XGLAR ONE is generally considered safe during pregnancy. However, it is crucial to consult your doctor to discuss the potential risks and benefits, as your insulin dose may need adjustment. During Breastfeeding: XGLAR ONE is probably safe to use during breastfeeding, as limited human data suggests it does not pose a significant risk to the baby. Nevertheless, your insulin requirements might change, so regular monitoring is important.

Can XGLAR ONE be taken with other medications?

Yes, XGLAR ONE can be used alone or in conjunction with faster-acting insulins or other antidiabetic medications. However, many medications can affect how insulin acts, potentially requiring dose modifications. For example, certain oral antidiabetic agents and ACE inhibitors can increase the risk of hypoglycemia, while corticosteroids can reduce insulin's effectiveness. Beta-blockers may mask the symptoms of low blood sugar. Always inform your doctor about all medications you are taking.

What precautions should be taken while using XGLAR ONE?

Do not use XGLAR ONE if you have existing low blood sugar levels (hypoglycemia) or an allergy to insulin glargine. Inform your doctor about any pre-existing kidney, liver, or heart conditions. It is important to monitor your blood sugar levels regularly, especially during illness, changes in diet, exercise, or stress. Rotate the injection site to prevent skin changes, and carry a source of sugary food to treat mild hypoglycemia. Avoid excessive alcohol consumption, as it can increase the risk of hypoglycemia and mask its symptoms. Exercise caution when driving or operating machinery, as blood sugar fluctuations can affect concentration.

What happens if a dose of XGLAR ONE is missed?

If a dose is missed, take it promptly. However, if your next scheduled dose is approaching, skip the missed dose and return to your regular dosing schedule. Do not take a double dose to compensate for a missed one, as this can lead to a dangerous drop in blood glucose levels.

How should XGLAR ONE be stored?

XGLAR ONE should be stored in a refrigerator at a temperature between 2-8°C. It is important not to freeze the medication. Keep it away from direct sunlight and out of the sight and reach of children.